Health
UK Scientists Uncover Breakthrough in Asthma and COPD Treatment
A new treatment approach for asthma and chronic obstructive pulmonary disease (COPD) has been identified by scientists in the UK, marking what is being hailed as the first major advancement in managing these conditions in half a century.
The findings, published in The Lancet Respiratory Medicine, reveal that a single injection of benralizumab, a monoclonal antibody, is significantly more effective than traditional steroid tablets in reducing symptom flare-ups, known as eosinophilic exacerbations. These episodes account for roughly 50% of asthma attacks and 30% of COPD attacks, causing symptoms such as wheezing, coughing, and chest tightness.
A New Approach to Inflammation
Steroid tablets, the conventional treatment, work by reducing inflammation in the lungs but are not effective for all patients and can lead to serious long-term side effects like high blood pressure and osteoporosis. In contrast, benralizumab targets white blood cells to reduce lung inflammation, curbing symptoms and lowering the need for additional treatments by 30%, according to the study.
“This could be a game-changer for people with asthma and COPD,” said Dr. Mona Bafadhel, lead investigator and chair of respiratory medicine at King’s College London.
Widespread Impact
COPD affects an estimated 36.6 million Europeans, while nearly 10 million people under 45 have asthma. These conditions significantly impact patients’ quality of life, particularly older individuals with both diseases, who often face limited life expectancies.
“We need to provide these patients with life-saving options before their time runs out,” said Dr. Sanjay Ramakrishnan, a study author and clinical senior lecturer at the University of Western Australia. He criticized current treatments as being “stuck in the 20th century.”
Trial Highlights
The study divided high-risk asthma and COPD patients into three groups: one received benralizumab, another steroids, and the third both treatments.
After 28 days, those treated with benralizumab showed better respiratory outcomes. At the 90-day mark, 74% of steroid-treated patients required further medical intervention due to treatment failure, compared to only 45% of those who received the antibody injection.
The findings suggest that a single benralizumab injection could become a vital emergency treatment, reducing hospital readmissions for asthma and COPD patients.
A Pivotal Moment in Respiratory Care
“We hope these pivotal studies will change how asthma and COPD exacerbations are treated for the future, ultimately improving the health for over a billion people living with asthma and COPD across the world,” Bafadhel stated.
The trial, supported by AstraZeneca and the University of Oxford, offers renewed hope for better management of respiratory diseases, potentially transforming care for millions globally.
Health
Global Mental Health Cases Near 1.2 Billion as Anxiety and Depression Drive Sharp Worldwide Rise
A major global analysis has found that mental health conditions have surged to an estimated 1.2 billion people worldwide, driven largely by steep increases in anxiety and depression over the past three decades.
The findings, published in The Lancet as part of the Global Burden of Disease Study 2023, show that the number of people living with mental disorders has almost doubled since 1990, marking a 95% rise. Researchers say major depressive disorder and anxiety disorders have seen even sharper growth, increasing by 131% and 158% respectively, making them the most prevalent mental health conditions globally.
The report describes mental illnesses as widespread conditions that create long-term disability and significant human suffering. It also highlights broader consequences for economies and public services, including reduced productivity, lower workforce participation and increasing pressure on health and welfare systems.
Researchers estimate that in 2023 alone, around 620 million females and 552 million males were affected by mental health conditions. While the overall burden is rising across both sexes, the study points to notable differences in the types and prevalence of disorders.
Among women, depression and anxiety were the most commonly reported conditions, alongside higher rates of eating disorders such as anorexia nervosa and bulimia nervosa. The report links this disparity to a mix of biological, social and structural factors, including exposure to domestic violence, sexual abuse, gender inequality and reproductive health-related changes.
In contrast, neurodevelopmental and behavioural disorders, including attention deficit hyperactivity disorder (ADHD), conduct disorder and autism spectrum conditions, were more frequently diagnosed in men.
Teenagers aged 15 to 19 were identified as the group experiencing the highest mental health burden globally, raising concerns about early onset of conditions and insufficient preventive care for young people.
The study identifies several key risk factors associated with mental illness, including childhood sexual violence, bullying and intimate partner violence. These factors are strongly linked to conditions such as depression, schizophrenia, bipolar disorder and anxiety disorders. However, researchers note that such exposures have remained relatively stable over time and account for only a portion of the overall rise.
According to the authors, broader drivers are likely contributing to the increasing prevalence of mental disorders. These include genetic and biological influences, poverty, inequality, and the growing impact of global crises such as armed conflict, pandemics, natural disasters and climate-related stress.
While mental health conditions have long been a leading cause of disability worldwide, the report warns that the situation is worsening. At the same time, health systems have not expanded services at a pace matching demand.
The authors caution that the gap between rising need and limited access to care is becoming more pronounced, leaving millions without adequate treatment or support.
Health
Europe Records Sharp Rise in Sexually Transmitted Infections, ECDC Warns
Health
White House Rejects Report It Blocked Return of Ebola-Infected US Doctor
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
